Comparison of tumor and stroma CD73 expression with TLR9 and survival in breast cancer

被引：0
|
作者：
Selander, K.
Mella, M.
Kauppila, J.
Karihtala, P.
Jukkola-Vuorinen, A.
Auvinen, P.
Soini, Y.
Kauppila, S.
Haapasaari, K-M
Harris, K.
Vuopala, K.
机构：
[1] Oulu Univ Hosp, Oulu, Finland
[2] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Lapland Cent Hosp, Rovaniemi, Finland
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P4-04-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-04-13
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
    Supernat, Anna
    Markiewicz, Aleksandra
    Welnicka-Jaskiewicz, Marzena
    Seroczynska, Barbara
    Skokowski, Jaroslaw
    Sejda, Aleksandra
    Szade, Jolanta
    Czapiewski, Piotr
    Biernat, Wojciech
    Zaczek, Anna
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (02): : 103 - 107
  • [22] CD73: a new biomarker in triple-negative breast cancer
    Lafont, Virginie
    Michaud, Henri-Alexandre
    Bonnefoy, Nathalie
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S594 - S596
  • [23] High CD73 expression, regulated by estrogen signaling, associates with cancer aggressiveness in estrogen receptor (+) breast cancer
    Katsuta, Eriko
    Anand, Vivek
    Yan, Li
    Dasgupta, Subhamoy
    Takabe, Kazuaki
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
    Tuomela, Johanna
    Sandholm, Jouko
    Karihtala, Peeter
    Ilvesaro, Joanna
    Vuopala, Katri S.
    Kauppila, Joonas H.
    Kauppila, Saila
    Chen, Dongquan
    Pressey, Christine
    Harkonen, Pirkko
    Harris, Kevin W.
    Graves, David
    Auvinen, Paivi K.
    Soini, Ylermi
    Jukkola-Vuorinen, Arja
    Selander, Katri S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 481 - 493
  • [25] Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
    Johanna Tuomela
    Jouko Sandholm
    Peeter Karihtala
    Joanna Ilvesaro
    Katri S. Vuopala
    Joonas H. Kauppila
    Saila Kauppila
    Dongquan Chen
    Christine Pressey
    Pirkko Härkönen
    Kevin W. Harris
    David Graves
    Päivi K. Auvinen
    Ylermi Soini
    Arja Jukkola-Vuorinen
    Katri S. Selander
    Breast Cancer Research and Treatment, 2012, 135 : 481 - 493
  • [26] Expression of CD39 and CD73 as a means of evading anti-tumor immune reponses in lung cancer
    Meyer, Christian
    Rosinsky, Carolyn
    Alme, Angela
    Rowell, Jonathan
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [27] Investigation of CD73 expression in response to immunotherapy in pan-cancer
    Wang, Y.
    Liu, M.
    Hu, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S893 - S893
  • [28] Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Katsuta, Eriko
    Dasgupta, Subhamoy
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S34 - S34
  • [29] Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
    Gardani, Carla Fernanda Furtado
    Pedrazza, Eduardo Luiz
    Paz, Victoria Santos
    Zanirati, Gabriele Goulart
    da Costa, Jaderson Costa
    Andrejew, Roberta
    Ulrich, Henning
    Scholl, Juliete Nathali
    Figueiro, Fabricio
    Rockenbach, Liliana
    Morrone, Fernanda Bueno
    PHARMACEUTICALS, 2023, 16 (11)
  • [30] Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
    Kowash, Ryan R.
    Akbay, Esra A.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345